ArticleScientific reports2025
DRCNN-Lesion Proxy: a hybrid CNN with lesion-inspired feature simulation for diabetic retinopathy severity classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI driven Hybrid CNN transformer model for early detection and severity assessment of diabetic retinopathy.Scientific reports · 2026Article
- A panoramic perspective: application prospects and outlook of multimodal artificial intelligence in the management of diabetic retinopathy.Frontiers in public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic Retinopathy (DR) remains a leading cause of vision loss globally, necessitating accurate and scalable diagnostic solutions. Existing Deep Learning (DL) models often underutilize lesion-specific cues that are critical for early DR grading, while detection based models require costly lesion annotations. To address these limitations, we propose DRCNN-Lesion Proxy, a hybrid architecture that integrates a ResNet34 based CNN backbone for extracting global image level features with a Lesion Proxy Module, which simulates lesion-inspired cues without explicit lesion bounding box annotations. These heterogeneous features are fused through a late fusion classification head to enable robust multiclass DR severity prediction. The model was trained on a composite dataset and rigorously evaluated across six publicly available benchmarks namely EyePACS, Messidor-2, APTOS 2019, DDR, DIARETDB1, and IDRiD. Experimental findings show that the proposed framework consistently outperforms baseline CNNs and recent hybrid methods, achieving up to 98.37% accuracy, 97.28% F1-score, and 98.14% AUC. Statistical significance testing confirmed that these improvements were not due to chance. Furthermore, Grad-CAM visualizations highlighted clinically relevant retinal regions, and a pilot validation with three ophthalmologists on 20 cases reported mean scores above 3.5 out of 5, confirming that the explanations were perceived as clinically meaningful and useful for grading. The proposed framework provides an annotation light solution with strong generalizability, diagnostic precision, and clinically validated interpretability, advancing the state of the art in automated DR screening and offering a practical pathway for real world deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.